Parkinson's Disease Clinical Trials in San Antonio

Showing 21-40 of 132 trials

Combining Aerobic Exercise and Virtual Reality for Cognitive-motor Rehabilitation in PD

NCT05385497

This project will provide preliminary data on the feasibility and effects of exercise and VR on motor behavior and neuroplasticity in PD. Results from this work will provide insight into whether combination interventions utilizing AE and VR have parallel effects on cognition, gait, and neuroplasticity in PD.

Parkinson's Disease

The University of Texas Health Science Center at San Antonio10 participantsStarted Nov 2022

San Antonio, Texas, United States

TERMINATEDPhase 2/3< 1 mile

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

NCT04857359

This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia (randomized 1:1 to receive active or placebo) for 12 weeks (1 week at 150 mg per day and 11 weeks at 300 mg per day). The primary efficacy assessment will be based on the Unified Dyskinesia Rating Scale (UDysRS). Patients who complete the 12-week blinded treatment period may have the option to roll into an open-label safety extension study for an additional 12-month treatment period.

Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias

Addex Pharma S.A.25 participantsStarted Aug 2021

Phoenix, Arizona, United States • Fresno, California, United States • Irvine, California, United States +38 more locations

Combining Aerobic Exercise and Virtual Reality for Cognitive-motor Rehabilitation in PD

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson's Disease Trials in Other Cities

Parkinson's Foundation PD GENEration Genetic Registry

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

STEM-Parkinson's Disease

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

STEM-PD Open Label Extension (OLE)

Wearable Assessments in the Clinic and Home in PD

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

Visualization of the STN and GPi for DBS

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Other Conditions in San Antonio